Dr. Emily Dykhuizen

Biography

Emily C. Dykhuizen is a Professor in the Borch Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University. She focuses on the intersection of chemical biology and chromatin biology, with her research primarily concentrating on the role of chromatin structure in cancer development and progression. Her recent studies utilize genome sequencing and CRISPR-based screening to investigate mutations that depend on epigenetic regulators in cancer. Dykhuizen aims to uncover how chromatin remodeling complexes, through their chromatin binding domains, contribute to biological functions, particularly in the context of cell fate transitions and therapy resistance in cancer. She is also interested in high-throughput screening for chromatin regulator inhibitors and conducting proteomic analyses of chromatin modifying complexes, especially those with subunit mutations in human malignancies. Dykhuizen leads a dynamic lab at Purdue University where she mentors students and postdoctoral researchers in these vital areas of study.

Research Interests